Pages
Have your say on plan to improve city’s health and care support services
https://dchs.nhs.uk/news/have-your-say-plan-improve-citys-health-and-care-support-services
Ashbourne poet’s thanks in verse for NHS nurses is unveiled at St Oswald’s Hospital
https://dchs.nhs.uk/news/ashbourne-poets-thanks-verse-nhs-nurses-unveiled-st-oswalds-hospital
Diabetes Education Service
Understanding your Type 2 diabetes is important so you can learn how to control it and have the best quality of life possible.
Files
0273 - OT Environment Measurement Information Sheet Carer
0273 - OT Environment Measurement Information Sheet Carer
0508 - Index Dividers In-Patients
0508 - Index Dividers In-Patients
Identification and Management of Moisture Lesions (L34)
Identification and Management of Moisture Lesions
1058 - Palliative Care Syringe Driver Prescription Information Sheet Patients aged 18 years and over
1058 - Palliative Care Syringe Driver Prescription Information Sheet Patients aged 18 years and over
L23 - Information about your steroid injection
Patient information leaflet about your steroid injection.
Peripheral Arterial Disease (PAD) Protocol for Podiatrists (S22)
The purpose of this document is to provide an evidence based approach to the diagnosis and podiatric management of PAD and in particular to identify monitoring and onward referral triggers thus ensuring high quality care which is appropriate, effective and equitable across the Service.
0316 Enhanced Observation Monitoring Form.docx
0316 Enhanced Observation Monitoring Form
Identification Policy for Patients (P70)
Derbyshire Community Health Services NHS Foundation Trust (DCHS) aims to take all reasonable steps to ensure the safety of patients by having robust systems in place to confirm a patient’s identify. This policy provides guidance for staff to reduce the risk of misidentification of patients using the guidance issued in the National Patient Safety Agency (NPSA) Safer Practice Notice (2007) “Standardising wristbands improves patient safety”. This policy aims to: • Reduce the potential of harm to patients caused by misidentification; • Ensure compliance with National Patient Safety Agency (NPSA) advice.
SCALE (Skin Changes at Life’s End) Leaflet (L205)
SCALE (Skin Changes at Life’s End) Leaflet
Declaration - Public B C NED.pdf
Public B C NE Declaration